By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Aratana Therapeutics 

1901 Olathe Blvd

Kansas City  Kansas  66103  U.S.A.
Phone: 913-951-2130 Fax: n/a


SEARCH JOBS








Company News
Aratana Therapeutics (PETX) Files For FDA Approval Of NOCITA (Bupivacaine Liposome Injectable Suspension) 6/30/2016 8:26:37 AM
Aratana Therapeutics (PETX) Appoints Chief Operating Officer 6/30/2016 6:14:04 AM
Aratana Therapeutics (PETX) Receives CMC Technical Section Complete Letter For Post-Operative Pain Therapeutic 6/2/2016 9:51:32 AM
Aratana Therapeutics (PETX) To Participate At Two Upcoming Investor Conferences 5/23/2016 7:53:17 AM
Aratana Therapeutics (PETX) Granted FDA Approval Of ENTYCE (Capromorelin Oral Solution) 5/18/2016 6:11:38 AM
Aratana Therapeutics (PETX) Reports First Quarter 2016 Financial Results 5/6/2016 6:29:33 AM
Aratana Therapeutics (PETX) To Present At Bank of America (BAC) Merrill Lynch Healthcare Conference 5/2/2016 9:27:42 AM
Aratana Therapeutics (PETX), Elanco Announce Global Strategic Collaboration 4/26/2016 10:08:46 AM
Aratana Therapeutics (PETX) To Discuss Global Strategic Collaboration With Elanco Animal Health 4/26/2016 6:05:34 AM
Aratana Therapeutics (PETX) To Report First Quarter 2016 Financial Results 4/15/2016 6:52:22 AM
12345678910...
//-->